A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
Clinical trial NCT01860638 · COMPLETED
Trial details
- NCT number
- NCT01860638
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-19
- Primary completion
- 2017-01-13
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.